Member Info for tomvisual

Telegraph reporting that pooled testing to be used to help Government hit 'moonshot' target
Method involves combining small amounts of all coronvairus test swabs in a batch into single test tube, saving time and resources.
https://www.telegraph.co.uk/politics/2020/09/15/pooled-testing-used-help-government-hit-moonshot-target/

Ministers plan to hit their controversial "moonshot" target to conduct 10 million tests a day by combining up to 50 samples for a single result.

The method, known as pooled testing, involves combining small amounts of all the swabs in a batch into a single test tube.

If Covid-19 is not detected in the composite sample, all patients are deemed negative. If any virus is found, all original swabs are then tested individually.

The technique intended to save time and scarce resources, would enable Boris Johnson to claim victory in his highly ambitious plan, announced earlier this month, while having physically tested only a fraction of the declared daily results.
Test, test, test

Acro, several RNS are due highlighting each Work Package Milestone Completion
https://www.paraytec.com/news-events/post86/rapid-test-for-the-presence-of.html
As we are less than 3 weeks from October, I would expect these to start to be delivered in quick succession as the Milestones reach their delivery date of October.
Has anyone researched the tech that Paraytec are using?
Test, test, test

When the super lab at Cambridge was set up, Primerdesign provided the test assay, AZ and GSK the hardware.
Cambridge University provided the students to run the tests.
Well, who would have thought it, that students and academics who were manning the test processing centres would return to their studies and research at the start of the academic year?
The answer is that people who took the trouble to find out how the system they were supposed to be managing actually operated would have appreciated that a significant part of their labour force would become unavailable after mid September.
It is not NHS Test and Trace at all. It is an utter shambles run by Boris's private sector pals, for vast sums of taxpayer money.

Rant over.
This lack of foresight, has gifted Paraytec with an opportunity to meet their milestones in the same time that new resource is trained to used the test hardware at the Government centralised PCR test Centres.
BRH has not missed the boat, it's test methodology is required!
Test, test, test

When the super lab at Cambridge was set up, Primerdesign provided the test assay, AZ and GSK the hardware.
Cambridge University provided the students to run the tests.
Well, who would have thought it, that students and academics who were manning the test processing centres would return to their studies and research at the start of the academic year?
The answer is that people who took the trouble to find out how the system they were supposed to be managing actually operated would have appreciated that a significant part of their labour force would become unavailable after mid September.
It is not NHS Test and Trace at all. It is an utter shambles run by Boris's private sector pals, for vast sums of taxpayer money.
Test, test, test

Chart looking very positive!

In the run up to October I anticipate a rns at each project milestone. So lots of news in the pipeline over the next 3 weeks.
Test, test, test

25.54p paid. Break out. X20-50 bagger potential here. Very low market cap for a covid19 stock
Test, test, test

23.9p paid.
Market cap is ridiculously low for a covid stock.
Test, test, test

Is BRH on the move?
Stock price has now triggered my entry level!
Would not surprise me if it made Zak Mir's Bulletin Board Hero list this week.
Test, test, test

R4 Today (14/9/20) @ 7:20 poo pooing sewerage monitoring as infopandemic of false news.
Why are some many people ill informed?
Test, test, test

Randox is explaining the voiding of 35,000 test kits since the start of August, but how is a mere 62,000 tests per day in early September explained?

Interesting that I was hearing about masks, possibly, helping with immunity to Covid-19 by exposing the wearer to small doses, on the Coronacast podcast, yesterday.
I had not been aware of the history of people deliberately exposing their children to low doses of Smallpox, before Dr Jenner's vaccine.
Test, test, test

Telegraph article on hypothesis that face mask wearing might be reducing the severity of the virus and ensuring that a greater proportion of new infections are asymptomatic ...

https://www.telegraph.co.uk/global-health/science-and-disease/face-masks-could-giving-people-covid-19-immunity-researchers/

Looks like BRH may potentially have more to offer as we approach second wave, Pharm2Farm's anti-viral face mask.
#nanotechnology #PPE #facemasks

Not expecting rns on Monday.
With the R number >1, most covid stocks will be boosted as investors change their investments.
Share price above around 23.3 is a confirmation signal to me. Volume has increased but not significantly.
Not wanting to ramp or de-ramp!
The one thing that gives BRH greater potential than most covid stocks is the market cap. Its very low so lots of potential for shsre price movement.
As the time to October ticks down and the project milestones are met then rns's will follow which no doubt will boost the share price.
Can the 5 minute test be rapidily rolled out?
Thats the £350M questiin for me!
I hope Paraytec are in discussions with Govt organisations overviewing the UK test strategy. No doubt NDAs would then be involved. Seen news blackouts with other covid stocks.
Note, Govt has £100B war chest to spend!
5 minute test is a massive differentiator to what we have available at the moment - 72 hours for a result was advised by one parent at a local school where I live.
Will be interesting to see where this goes as October approaches.
Risk vs Reward nakes this a very attractive covid share to me.
Test, test, test

PL75, I really wonder if the saliva testing was more focused on the LAMP Optigene test. LAMP from what I have read is comparable to PCR in terms of Sensitivity and Specificity.
test, test, test

alwayznow, can you advise source of this information?

Extrader, I reached the same conclusion.
As this was ipo'd before covid surely a lot of the deals/mechanucs of operation were in the pipeline/developed.
But apparently this is not the case.
Rather raise a few questions before fully committing!

Ponyboy, I do appreciate where this share has the potential to go, thats why I long.
Just pointing out that the share price targets with share dilution are substantially less in real terms than what was initially calculated when I bought. Perhaps this does not matter, but it does cap my gains if I am correct!
Hence the need to ask AZ about placing for II to buy in.

None of the fundamentals have changed.
Long Syme, but...
My take on Syme, is that if II want in, share price will fall. Then I assume placing providing a X% dilution (hopefully not at a discount but don't bet on it!) to allow the II to buy in.
At what price does this occur?
Assuming at 0.35p and 25% placing, for those in at 0.7 and greater potential gains will be substantially reduced!
We need to ask AZ if he would consider a placing for II to get in or would they need to buy at market price.
Note as main holders unload shares for the II, this has been shown to reduce the share price.
PIs are caught between a rock and a hard place depending our entry price!
Not ramping or deramping, just reporting what i think.

Wiggly, this info is not dated. Looks to me that it refers to the initial creation of the collaboration between GSK,AZ and University of Cambridge. Primerdesign PCR test was the test that was resourcd. The university provided students to run the tests and GSK, AZ hardware to support the testing.
Thus should still be up and running, but us focused in PCR from Primerdesign.

Test, test, test